Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:TORC

resTORbio (TORC) Stock Price, News & Analysis

resTORbio logo

About resTORbio Stock (NASDAQ:TORC)

Key Stats

Today's Range
$0.94
$1.06
50-Day Range
$2.28
$14.77
52-Week Range
$0.86
$10.50
Volume
1.03 million shs
Average Volume
1.15 million shs
Market Capitalization
$35.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Adicet Bio, Inc. is a biotechnology company which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Receive TORC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for resTORbio and its competitors with MarketBeat's FREE daily newsletter.

TORC Stock News Headlines

Adicet Bio Inc (ACET)
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
TinOne Resources Inc. (TORC.V)
See More Headlines

TORC Stock Analysis - Frequently Asked Questions

resTORbio, Inc. (NASDAQ:TORC) posted its quarterly earnings data on Thursday, July, 30th. The company reported ($0.15) EPS for the quarter, beating analysts' consensus estimates of ($0.22) by $0.07.

resTORbio (TORC) raised $86 million in an IPO on Friday, January 26th 2018. The company issued 5,700,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch, Leerink Partners and Evercore ISI acted as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that resTORbio investors own include Novavax (NVAX), VBI Vaccines (VBIV), AbbVie (ABBV), Dynavax Technologies (DVAX), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE) and CRISPR Therapeutics (CRSP).

Company Calendar

Last Earnings
7/30/2020
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TORC
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-82,740,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.24 per share

Miscellaneous

Free Float
N/A
Market Cap
$35.25 million
Optionable
Not Optionable
Beta
2.43
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:TORC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners